/ 100
Molbio Diagnostics Limited (MOLBIO) — Technical Setup
₹1,394.10 +5.73% Uptrend Normal Volatility Neutral
Summary
Molbio Diagnostics Limited is in a uptrend on the daily chart. RSI(14) is 55.5, MACD is above its signal line, ADX reads 20 (weak trend). Volume in the latest session was 2.1× its 20-day average. Nearest support is ₹1,246.55 and resistance ₹1,398.00. Its technical score is 47/100 (neutral).
🧮 How the 47/100 is built
Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.
- Close above 20-day EMA (3.40)3/3
- 20-day EMA above 50-day EMA3/3
- 50-day EMA above 200-day EMA0/3
- Close above 200-day SMA0/3
- SuperTrend (10,3) pointing up3/3
- ADX ≥ 20 with +DI above −DI (trend has strength) (19.99)1/3
- Weekly trend up (above a rising 30-week average)0/2
- RSI(14) in the bullish zone (55-70 best) (55.50)6/6
- MACD line above its signal line4/4
- MACD line above zero (4.05)3/3
- 12-day rate of change positive (9.47)3/3
- Stochastic %K above %D2/2
- Outperforming the Nifty 50 over 3 months0/2
- On-balance volume rising over 20 sessions5/5
- Chaikin Money Flow (20) positive (-0.11)0/5
- More volume on up days than down days (20 sessions) (1.50)5/5
- Close above 20-day VWAP (-2.14)0/5
- Daily range (ATR%) contained — ≤2.5% scores full (6.57)0/6
- Price in the upper half of its Bollinger Bands (0.64)5/5
- Shallow drawdown from the 52-week high (-17.35)3/5
- Volatility contracting (20-day volatility below its 6-month median)0/4
- Room to the next resistance (≥8% scores full) (0.28)0/5
- Support close below (a tight, definable stop) (10.58)1/5
- Broke above a 20-day high in the last 5 sessions0/5
- Within 5% of the 52-week high (-17.35)0/5
🧭 Regime: Uptrend
Normal Volatility.
Suits: Trend-following, selectively. The trend is up but not forceful — favour entries near support and keep stops below the 50-day EMA.
Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.
Opens the AI Backtester with the 20/50 EMA Crossover rules for MOLBIO — 20-day ema crosses above the 50-day ema.
🕰️ Multi-timeframe
| Timeframe | Trend | RSI (14) | MACD hist. |
|---|---|---|---|
| Monthly | — | — | — |
| Weekly | — | — | — |
| Daily | ▲ Bullish | 55.51 | 0.61 |
Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: —, weekly ADX —.
📶 Volume & VWAP
VWAPs are computed from daily bars (typical price × volume), not intraday ticks. Price fell over 20 sessions while OBV rose (bullish price-volume divergence).
💪 Relative strength
MOLBIO ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.
🧱 Support & resistance
Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.
| Level | Price | Distance | Touches |
|---|---|---|---|
| Resistance | ₹1,680.25 | +20.5% | 2 |
| Resistance | ₹1,583.80 | +13.6% | 1 |
| Resistance | ₹1,398.00 | +0.3% | 1 |
| Close | ₹1,394.10 | — | |
| Support | ₹1,246.55 | −10.6% | 2 |
| Support | ₹1,035.20 | −25.7% | 1 |
52-week range: ₹926.35 – ₹1,686.80 (-17.35% from the high).
🌀 Fibonacci
Measuring the up-swing from ₹926.35 (2026-08-17) to ₹1,686.80 (2026-09-11). Price has retraced 38.5% of it.
| Ratio | Price | Distance | |
|---|---|---|---|
| 23.6% retracement | ₹1,507.33 | +8.1% | |
| 38.2% retracement | ₹1,396.31 | +0.2% | S/R confluence nearest |
| 50.0% retracement | ₹1,306.58 | -6.3% | |
| 61.8% retracement | ₹1,216.84 | -12.7% | |
| 78.6% retracement | ₹1,089.09 | -21.9% | |
| 127.2% extension | ₹1,893.64 | +35.8% | |
| 161.8% extension | ₹2,156.76 | +54.7% | |
| 200.0% extension | ₹2,447.25 | +75.5% |
Next Fibonacci time zone: 89 sessions from the swing start ≈ 2026-12-24 (approximate — exchange holidays are not modelled).
🕯️ Candlesticks (last 5 sessions)
Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.
↗️ Divergences
No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.
✅ Screens MOLBIO passes today
| Stock | Close | Chg | Score | Trend regime | RS rating (1-99) |
|---|---|---|---|---|---|
| YATHARTHYatharth Hospital & Trauma Care Services Limited | ₹1,060.35 | +1.69% | 89 | Uptrend | 89.00 |
| AGARWALEYEDr. Agarwal's Health Care Limited | ₹551.25 | -0.52% | 85 | Strong Uptrend | 75.00 |
| LALPATHLABDr. Lal Path Labs Ltd. | ₹2,008.80 | -0.98% | 78 | Strong Uptrend | 81.00 |
| MEDANTAGlobal Health Limited | ₹1,439.70 | +0.75% | 77 | Range | 75.00 |
| APOLLOHOSPApollo Hospitals Enterprise Limited | ₹8,515.00 | -1.03% | 76 | Range | 69.00 |
| INDGNIndegene Limited | ₹666.05 | +8.12% | 76 | Uptrend | 84.00 |
| METROPOLISMetropolis Healthcare Limited | ₹565.20 | -1.90% | 76 | Strong Uptrend | 70.00 |
| POLYMEDPoly Medicure Limited | ₹1,693.10 | +1.18% | 73 | Range | 53.00 |
| SYNGENESyngene International Limited | ₹447.80 | +1.12% | 73 | Strong Uptrend | 52.00 |
| MAXHEALTHMax Healthcare Institute Limited | ₹946.30 | +1.94% | 72 | Range | 39.00 |
⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.
